Last $1.12 USD
Change Today +0.07 / 6.67%
Volume 912.8K
STEM On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rodney K. B. Young

Former Chief Financial Officer and Vice President of Finance & Administration, StemCells Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

51--

Background*

Mr. Rodney K. B. Young served as the Chief Financial Officer and Vice President - Finance and Administration at Stemcells Inc. from September 6, 2005 to January 1, 2014 and from November 2006 to January 1, 2014 respectively. Mr. Young served as Vice President of Finance of StemCells Inc. from September 6, 2005 to January 2007. He served as Senior Vice President of Global Healthcare at Lehman Brothers, Inc. Mr. Young has financial and administrative experience in the ...

Read Full Background

Corporate Headquarters*

7707 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-456-4000
Fax: 510-456-4001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
The University of Chicago
MBA
The University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:US $1.12 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Vericel Corporation
$358.3K
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board
Bioheart, Inc.
$766.7K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$360.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMCELLS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.